FDA Rebukes Pfizer Over Late Reports Of Side Effects

Law360, New York (June 10, 2010, 3:11 PM EDT) -- Pfizer Inc. has confirmed that it received a warning from the U.S. Food and Drug Administration for not reporting post-marketing side effects from its drugs in a timely fashion.

The pharmaceutical giant acknowledged Wednesday that it had received the warning June 3 related to an FDA inspection that ended in August 2009.

A Pfizer spokeswoman confirmed that the drugmaker had forwarded a copy of the FDA letter to Reuters but did not immediately provide the warning to Law360 on Thursday.

The FDA's 12-page letter related to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.